SCHEMBL6324023

SCHEMBL6324023

Cn1c(=O)c2nc(C=O)c(NC3CC3)nc2n(C)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 2/20 0.40
JAK2 O60674 1/20 0.40
HTT P42858 1/20 0.40
PAX8 Q06710 1/20 0.40
ADORA2A P29274 6/20 0.38
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
MAPT P10636 2/20 0.35
ADORA2B P29275 3/20 0.35
GAA P10253 2/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6323060 0.78 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6313853 0.75 LMNA (0.46) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6321651 0.73 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6314126 0.73 CTSL (0.43) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6316016 0.70 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6316327 0.69 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL6316628 0.68 MAPK1 (0.42) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL10524326 0.67 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL12355771 0.66 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDLMNAJAK2
SCHEMBL5448291 0.63 ALDH1A1 (0.73) ALDH1A1KDM4EHPGDLMNAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 ALDH1A1 1744/4885KDM4E 1278/4885HPGD 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.